Shan Jiang is a bioinformatics scientist at Eli Lilly and Company, specializing in drug discovery and computational biology with over 10 years of experience in large-scale genomics analysis. Shan has led numerous projects in Immuno-Oncology and drug development, including biomarker discovery and clinical trial support. Previously, Shan held roles at Pionyr Immunotherapeutics and AccuraGen, where they contributed to early cancer detection through bioinformatics methodologies and analysis. Shan earned a PhD in Developmental and Cell Biology Genomics from UC Irvine, where they participated in significant genomic research and publications.
This person is not in the org chart
This person is not in any teams
This person is not in any offices